Scioto Paint Valley Mental Health Ctr is a licensed substance use treatment provider in Chillicothe, OH, listed in the SAMHSA treatment directory. Long term residential treatment is available for people who need more than a short stay. Outpatient care is offered, so clients can keep living at home between scheduled sessions. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. Naltrexone is used to support recovery from opioid or alcohol use disorder. The program treats co-occurring mental health conditions alongside addiction. The facility reports accepting Medicaid. Private health insurance is accepted. It serves children/adolescents, young adults, adults.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Levels of care
OutpatientResidential/24-hour residentialOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatmentLong-term residentialShort-term residential
Type of care
Substance use treatmentTreatment for co-occurring disorders plus serious mental illness (SMI) in adults
Medications
Buprenorphine used in TreatmentNaltrexone used in Treatment
Payment accepted
Federal, or any government funding for substance use treatment programsMedicareMedicaidFederal military insurance (e.g., TRICARE)Private health insuranceCash or self-paymentState-financed health insurance plan other than MedicaidSAMHSA funding/block grants
Ages served
Children/AdolescentsYoung AdultsAdultsSeniors
Accreditation
State substance use treatment agencyState mental health departmentCommission on Accreditation of Rehabilitation Facilities (CARF)
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
Hospital inpatient/24-hour hospital inpatientOutpatientResidential/24-hour residentialFederal, or any government funding for substance use treatment programsFederal military insurance (e.g., TRICARE)
4449 State Route 159, 2nd Floor, Chillicothe, OH 45601
OutpatientOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatmentFederal, or any government funding for substance use treatment programsMedicare